---
title: "HSSP INTL 挫逾六成 下午 3 时 23 分起短暂停牌"
description: "HSSP INTL 于今日下午 3 时 23 分起在联交所短暂停牌，原因尚不明。该股今早高开 10.98%，最高见 11.5 元，但停牌前报 3.2 元，跌幅达 61.4%，成交额约 1 亿元。公司昨日公布与 Coty 达成协议，计划在阿联酋成立合资公司，East Nova 将持股 30%。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/263680706.md"
published_at: "2025-10-31T07:38:58.000Z"
---

# HSSP INTL 挫逾六成 下午 3 时 23 分起短暂停牌

> HSSP INTL 于今日下午 3 时 23 分起在联交所短暂停牌，原因尚不明。该股今早高开 10.98%，最高见 11.5 元，但停牌前报 3.2 元，跌幅达 61.4%，成交额约 1 亿元。公司昨日公布与 Coty 达成协议，计划在阿联酋成立合资公司，East Nova 将持股 30%。

HSSP INTL(03626.HK) 已於今日 (31 日) 下午 3 时 23 分起於联交所短暂停止买卖，未知悉原因。

HSSP INTL 今早高开 10.98%，最高见 11.5 元。停牌前报 3.2 元，跌 61.4%，成交额约 1 亿元。

该公司昨日 (30 日) 公布，旗下全资附属 East Nova 与 Coty 订立协议，计划於阿联酋成立一间合资公司，从事品牌电子烟设备分销业务，其中 East Nova 将持股 30%。

### Related Stocks

- [03626.HK - 启明东方控股](https://longbridge.com/zh-CN/quote/03626.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| REG - Jefferies Intl Ltd Just Group plc - Form 8.3 Just Group Plc | Jefferies International Limited disclosed its position in Just Group Plc under Rule 8.3 of the Takeover Code. As of Febr | [Link](https://longbridge.com/zh-CN/news/276323284.md) |
| REG - Jefferies Intl Ltd JTC PLC - Form 8.5 (EPT/NON-RI) JTC Plc | Jefferies International Limited disclosed its position regarding JTC plc in accordance with Rule 8.5 of the Takeover Cod | [Link](https://longbridge.com/zh-CN/news/276211562.md) |
| REG - Pacer Dev Mkts Intl£ - Net Asset Value(s) | Pacer Developed Market International Cash Cows 100 ETF has reported a net asset value (NAV) of $11,800,494.01, with 400, | [Link](https://longbridge.com/zh-CN/news/276442156.md) |
| REG - Jefferies Intl Ltd Picton Property Inc. - Form 8.5 (EPT/NON-RI) Picton Property Income Ltd | Jefferies International Limited disclosed its position regarding Picton Property Income Limited as of February 19, 2026. | [Link](https://longbridge.com/zh-CN/news/276430022.md) |
| Strategic Review at Charles River Laboratories Raises Deal Uncertainty, Execution Risks, and Shareholder Value Concerns | Charles River Laboratories Intl (CRL) faces increased deal uncertainty and execution risks due to an extensive strategic | [Link](https://longbridge.com/zh-CN/news/276306560.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。